Christopher Benecchi - 13 Feb 2025 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Signature
Brandon Marsh, attorney in fact for Christopher Benecchi
Issuer symbol
SAGE
Transactions as of
13 Feb 2025
Transactions value $
-$5,902
Form type
4
Filing time
14 Feb 2025, 16:27:04 UTC
Previous filing
21 Jan 2025
Next filing
11 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Tax liability -$5,901 -822 -1.84% $7.18 43,915 13 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 13, 2025, the reporting person vested 3,375 shares of time-based restricted stock units (RSUs) granted on February 13, 2024 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vests 25% on each grant anniversary date over four years. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.